On October 1st, the Crowdster Board of Directors and major investor, Canrock Ventures, announced the appointment of Joe Ferraro as the new CEO. The leadership change signals a strategic transformation at the software company that launched its crowdfunding platform in 2014.
Crowdster chairman, Mark Fasciano, stated:
“We are very pleased and fortunate to have Joe leading the Crowdster organization. I’m confident that Joe’s sales & marketing skills, particularly in the area of customer acquisition, combined with his tremendous energy will catapult the company forward.”
Ted Smith, Managing Director at Canrock Ventures, noted:
“Following an extensive search process, led by Jerry Angowitz, a Managing Director of Lloyd Executive Search, Joe has already demonstrated he is the right person to lead the company. His combination of energy, drive and keen understanding of what is important to non-profits, make him a perfect fit.”
Ferraro brings to the Crowdster team a long history of sales and marketing success, including twenty years in the fiercely competitive telecommunications industry and over a decade working in business process outsourcing where he managed Fortune 50 companies to deliver top of the line growth and superior customer excellence. In addition, Ferraro has worked alongside non-profits in addition to holding extensive leadership roles, allowing him to understand the environment these organizations are working in and the importance of fundraising.
Crowdster offers a unique product offering to non-profit organizations who are looking to raise funds for their causes by leveraging peer-to-peer fundraising. This includes event marketing capabilities, gamification along with social media integrated strategies and email marketing. The company website has relaunched last Friday with updated product details and a new pricing schedule which will simplify the relationship with their existing and prospective clients.
Crowdster clients have included the Major League Baseball (MLB), The Tiger Woods Foundation, Save the Children, Cystic Fibrosis Foundation, The Aga Khan Foundation, Bone Marrow Foundation and others.
